These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 20373463)

  • 1. Outcomes of liver transplantation in patients with cirrhosis due to nonalcoholic steatohepatitis versus patients with cirrhosis due to alcoholic liver disease.
    Malik SM; Ahmad J
    Liver Transpl; 2010 Apr; 16(4):533. PubMed ID: 20373463
    [No Abstract]   [Full Text] [Related]  

  • 2. Recurrent disease following liver transplantation for nonalcoholic steatohepatitis cirrhosis.
    Malik SM; Devera ME; Fontes P; Shaikh O; Sasatomi E; Ahmad J
    Liver Transpl; 2009 Dec; 15(12):1843-51. PubMed ID: 19938117
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nonalcoholic fatty liver disease after liver transplantation for cryptogenic cirrhosis or nonalcoholic fatty liver disease.
    Yalamanchili K; Saadeh S; Klintmalm GB; Jennings LW; Davis GL
    Liver Transpl; 2010 Apr; 16(4):431-9. PubMed ID: 20373454
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Management strategies in alcoholic liver disease.
    Tilg H; Day CP
    Nat Clin Pract Gastroenterol Hepatol; 2007 Jan; 4(1):24-34. PubMed ID: 17203086
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Outcomes of liver transplantation in patients with cirrhosis due to nonalcoholic steatohepatitis versus patients with cirrhosis due to alcoholic liver disease.
    Bhagat V; Mindikoglu AL; Nudo CG; Schiff ER; Tzakis A; Regev A
    Liver Transpl; 2009 Dec; 15(12):1814-20. PubMed ID: 19938128
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Patient with hepatitis B and alcoholic liver disease before and after liver transplantation.
    Ward SC; Chang CY; Peng L; Liu LU
    Semin Liver Dis; 2009 May; 29(2):233-7. PubMed ID: 19387922
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Frequency of Cardiovascular Events and Effect on Survival in Liver Transplant Recipients for Cirrhosis Due to Alcoholic or Nonalcoholic Steatohepatitis.
    Piazza NA; Singal AK
    Exp Clin Transplant; 2016 Feb; 14(1):79-85. PubMed ID: 26581602
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Non-alcoholic steatohepatitis - from NAFLD to MAFLD].
    Balmer ML; Dufour JF
    Ther Umsch; 2011 Apr; 68(4):183-8. PubMed ID: 21452138
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Outcomes of curative treatment for hepatocellular cancer in nonalcoholic steatohepatitis versus hepatitis C and alcoholic liver disease.
    Reddy SK; Steel JL; Chen HW; DeMateo DJ; Cardinal J; Behari J; Humar A; Marsh JW; Geller DA; Tsung A
    Hepatology; 2012 Jun; 55(6):1809-19. PubMed ID: 22183968
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Metabolic syndrome and nonalcoholic steatohepatitis recurrence after liver transplantation in children.
    Nobili V; Alisi A; de Ville de Goyet J
    Liver Transpl; 2011 May; 17(5):620-1. PubMed ID: 21351243
    [No Abstract]   [Full Text] [Related]  

  • 11. Challenges and Management of Liver Cirrhosis: Practical Issues in the Therapy of Patients with Cirrhosis due to NAFLD and NASH.
    Traussnigg S; Kienbacher C; Halilbasic E; Rechling C; Kazemi-Shirazi L; Hofer H; Munda P; Trauner M
    Dig Dis; 2015; 33(4):598-607. PubMed ID: 26159280
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Non-alcoholic fatty liver disease: further expression of the metabolic syndrome.
    Tarantino G; Saldalamacchia G; Conca P; Arena A
    J Gastroenterol Hepatol; 2007 Mar; 22(3):293-303. PubMed ID: 17295757
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Nonalcoholic steatohepatitis--current treatment options].
    Gutkowski K; Gutkowska D; Partyka M
    Przegl Lek; 2006; 63(2):91-4. PubMed ID: 16967716
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Steatosis degree, measured by morphometry, is linked to other liver lesions and metabolic syndrome components in patients with NAFLD.
    Boursier J; Chaigneau J; Roullier V; Lainé F; Sandrini J; Michalak S; Hubert I; Dib N; Oberti F; Bertrais S; Hunault G; Deugnier Y; Rousselet MC; Cavaro-Ménard C; Gallois Y; Aubé C; Calès P;
    Eur J Gastroenterol Hepatol; 2011 Nov; 23(11):974-81. PubMed ID: 21904208
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Liver transplantation in nonalcoholic steatohepatitis is associated with high mortality and post-transplant complications: a single-center experience.
    Heuer M; Kaiser GM; Kahraman A; Banysch M; Saner FH; Mathé Z; Gerken G; Paul A; Canbay A; Treckmann JW
    Digestion; 2012; 86(2):107-13. PubMed ID: 22846254
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Liver transplantation and non-alcoholic fatty liver disease.
    Zezos P; Renner EL
    World J Gastroenterol; 2014 Nov; 20(42):15532-8. PubMed ID: 25400437
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Hepatology 2007].
    Thimme R; Spangenberg HC; Blum HE
    Dtsch Med Wochenschr; 2007 Jun; 132(25-26):1392-5. PubMed ID: 17570087
    [No Abstract]   [Full Text] [Related]  

  • 18. [Is non alcoholic steatohepatitis (NASH) part of the metabolic syndrome?].
    Fehér J; Németh E; Lengyel G
    Orv Hetil; 2004 Jul; 145(29):1499-506. PubMed ID: 15453020
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Excellent posttransplant survival for patients with nonalcoholic steatohepatitis in the United States.
    Afzali A; Berry K; Ioannou GN
    Liver Transpl; 2012 Jan; 18(1):29-37. PubMed ID: 21932374
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Nonalcoholic fatty liver].
    Dancygier H
    Versicherungsmedizin; 2002 Mar; 54(1):11-5. PubMed ID: 11933860
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.